Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood filtering showdown: new hope for GBS patients?

NCT ID NCT04871035

Recruiting now Disease control Sponsor: University of Ulm Source: ClinicalTrials.gov ↗

First seen May 07, 2026 · Last updated Jun 11, 2026 · Updated 6 times

Summary

This study compares two blood-filtering treatments—immunoadsorption and plasma exchange—for people with Guillain-Barré syndrome (GBS), a rare nerve disorder that can cause muscle weakness and paralysis. Researchers will enroll 20 adults to see which method is safer and more effective at improving muscle strength and reducing disability. The goal is to find a better way to control the disease and speed up recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GBS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Neurology, University of Ulm

    RECRUITING

    Ulm, Baden-Wurttemberg, 89081, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

Guillain-Barre syndrome, familial

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GBS